NCT06915246View on ClinicalTrials.gov

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
LymphomaNon-Hodgkin LymphomaHodgkin Lymphoma
Interventions
DRUG

VI-0609

Carmustine with Propylene Glycol

DRUG

BiCNU

Carmustine with Ethanol

Trial Locations (4)

30265

RECRUITING

City of Hope Atlanta, Newnan

60099

RECRUITING

City of Hope Chicago, Zion

85338

RECRUITING

City of Hope Phoenix, Goodyear

91010

RECRUITING

City of Hope National Medical Center, Duarte

All Listed Sponsors
lead

VIVUS LLC

INDUSTRY